000 01262 a2200337 4500
005 20250513192648.0
264 0 _c19991001
008 199910s 0 0 eng d
022 _a0959-8049
024 7 _a10.1016/s0959-8049(98)00420-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBuske, C
245 0 0 _aMonoclonal antibody therapy for B cell non-Hodgkin's lymphomas: emerging concepts of a tumour-targeted strategy.
_h[electronic resource]
260 _bEuropean journal of cancer (Oxford, England : 1990)
_cApr 1999
300 _a549-57 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Murine-Derived
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aChimera
650 0 4 _aForecasting
650 0 4 _aHumans
650 0 4 _aImmunotoxins
_xtherapeutic use
650 0 4 _aLymphoma, B-Cell
_xtherapy
650 0 4 _aRituximab
700 1 _aFeuring-Buske, M
700 1 _aUnterhalt, M
700 1 _aHiddemann, W
773 0 _tEuropean journal of cancer (Oxford, England : 1990)
_gvol. 35
_gno. 4
_gp. 549-57
856 4 0 _uhttps://doi.org/10.1016/s0959-8049(98)00420-1
_zAvailable from publisher's website
999 _c10449934
_d10449934